Prognostic Impact of Deletions of Derivative Chromosome 9 in Patients With Chronic Myelogenous Leukemia Treated With Nilotinib or Dasatinib

BACKGROUND: Deletions of derivative chromosome 9 are a poor prognostic factor in patients with chronic myeloid leukemia (CML) treated with hydroxyurea, interferon, or stem cell transplantation. Imatinib may overcome the adverse prognostic impact of deletions of derivative chromosome 9. METHODS: A st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Quintás-Cardama, Alfonso, Kantarjian, Hagop, Shan, Jianqin, Jabbour, Elias, Abruzzo, Lynne V., Verstovsek, Srdan, Garcia-Manero, Guillermo, O'Brien, Susan, Cortes, Jorge
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4324753/
https://ncbi.nlm.nih.gov/pubmed/21523765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26147
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados